0001493152-20-017668.txt : 20200911 0001493152-20-017668.hdr.sgml : 20200911 20200911182200 ACCESSION NUMBER: 0001493152-20-017668 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200911 FILED AS OF DATE: 20200911 DATE AS OF CHANGE: 20200911 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schreiber Christopher C CENTRAL INDEX KEY: 0001750076 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36268 FILM NUMBER: 201171913 MAIL ADDRESS: STREET 1: AKERS BIOSCIENCES, INC. STREET 2: 201 GROVE ROAD CITY: THOROFARE STATE: NJ ZIP: 08086 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akers Biosciences, Inc. CENTRAL INDEX KEY: 0001321834 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 GROVE RD CITY: THOROFARE STATE: NJ ZIP: 08086 BUSINESS PHONE: 856-848-8698 MAIL ADDRESS: STREET 1: 201 GROVE RD CITY: THOROFARE STATE: NJ ZIP: 08086 FORMER COMPANY: FORMER CONFORMED NAME: Akers Biosciences Inc DATE OF NAME CHANGE: 20050325 4 1 ownership.xml X0306 4 2020-09-11 0 0001321834 Akers Biosciences, Inc. AKER 0001750076 Schreiber Christopher C C/O TAGLICH BROTHERS INC 709 NEW YORK AVENUE, SUITE 209 HUNTINGTON NY 11743 1 1 0 0 Exec. Chairman and President Restricted Stock Unit 2020-09-11 4 A 0 263500 0 A Common Stock 263500 263500 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Akers Biosciences, Inc. (the "Company"). The Company may also elect to settle the vested RSUs for cash at its discretion. Reporting Person was granted 263,500 RSUs under the Company's 2018 Equity Incentive Plan, as amended (the "Plan"), with fifty percent (50%) of the RSUs to vest on the first anniversary of the date of grant, and the remaining fifty percent (50%) to vest on the second anniversary of the date of grant; provided that the RSUs shall vest immediately upon the occurrence of (i) a change in control, provided that the Reporting Person is employed by or providing services to the Company and its affiliates on the closing date of such change in control, (ii) the Reporting Person's termination of employment or service from the Company and its affiliates by reason of the Reporting Person's death or disability, or (iii) the Reporting Person's termination of employment or service by the Company without cause. /s/ Christopher C. Schreiber 2020-09-11